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Podocytes undergo phenotypic changes and express macrophagic-
associated markers in idiopathic collapsing glomerulopathy. Collapsing
glomerulopathy (CG), a severe form of focal segmental glomerulosclerosis
(FSG), is characterized by tuft retraction and consolidation in numerous
glomeruli and changes in podocyte morphology and topography. Other
glomeruli are less affected. Collapsing glomerulopathy is also character-
ized by tubulointerstitial atrophy and fibrosis. The pathophysiology of the
glomerular and tubulointerstitial lesions is poorly understood. We studied
renal tissue of five Black and three White patients, all human immuno-
deficiency virus (HIV) negative, with nephrotic syndrome, renal failure,
and histological evidence of CG. Immunohistochemistry identified normal
podocyte phenotypes by podocalyxin, vimentin and complement receptor
1 (CR1) labeling. Three monoclonal antibodies were used to further
characterize podocyte epitopes: anti-CD68 clone KP1, anti-CD68 clone
PG-M1 and anti-M130 clone M18 (Ber-MAC3). Light microscopy of
collapsed glomeruli showed podocyte swelling, vacuolization, multinucle-
ation, “cobblestone-like” alignment around the glomerular tuft, and
pseudo-crescent formation in Bowman’s space. In collapsed glomeruli,
podocalyxin, vimentin and CR1 labeling tagged both normal and vacuo-
lated podocytes still attached to the GBM, but labeling was not found in
cobblestone-like podocytes or in podocytes detached from the GBM.
Conversely, numerous podocytes undergoing detachment and shedding
into Bowman’s space expressed macrophagic-associated epitopes. Cells
with macrophagic-associated epitopes clumped in cystically dilated tubules
and were aligned in tubules of smaller caliber. Their appearance was that
of viable cells. There was no morphologic indication that these cells
expressing macrophage-associated antigens originated from outside the
glomeruli or outside the tubules. We conclude that in CG podocytes
detach from the GBM, lose their normal podocytic phenotype and acquire
macrophage differentiation antigens. The presence of cells with such
antigens in tubular lumens suggests that detached metaplastic podocytes
progress along the tubule or, alternatively, that CG tubular cells also
undergo metaplastic changes into macrophage-like cells.
Focal segmental glomerulosclerosis is a nonspecific glomerular
lesion [1], defined by adhesion between the glomerular tuft and
Bowman’s capsule, collapse and/or hyaline obliteration of capil-
lary lumens, and frequently segmental deposition of IgM and C3.
Focal segmental glomerulosclerosis (FSG) is a variant or an
ominous complication of idiopathic nephrotic syndrome with
minimal glomerular changes [2–5]. It can also be observed in a
host of glomerular, vascular and tubulointerstitial human ne-
phropathies [1, 6–8]. FSG has been described in rat models based
on the toxic effect of puromycin aminonucleoside [9–12] or of
adriamycin [9, 13, 14], on subtotal reduction of renal mass [15–19],
in passive Heymann nephritis [20] and in Masugi nephritis [21].
Non-nephrotic FSG is also a feature of renal aging in humans [22]
and in the rat [23].
There is strong evidence that podocyte injury is the primary
lesion in all forms of FSG, including collapsing glomerulopathy.
In 1975 Grishman and Churg made the first electron microscopic
description of visceral epithelial cell degeneration in nephrotic
FSG [24]. Podocyte changes consisted of cytoplasmic degenera-
tion and detachment of visceral epithelial cells from basement
membranes with filling of the resulting space by cell debris and
extracellular matrix. Ten years later, Schwartz and Lewis shed
further light on the cellular lesion of FSG [25]. Their description
showed segmental proliferation, hypercellularity in Bowman’s
space and reactive changes in the podocytes. Electron microscopy
revealed cytoplasmic inclusions, absorption droplets within hyper-
trophied visceral epithelial cells and separation of some of these
podocytes from the glomerular basement membrane (GBM). This
work highlighted the key role of podocyte injury in the genesis of
capillary tuft collapse followed by sclerosis. Several further obser-
vations made on human renal biopsies [26–30] and in the rat [10,
18, 21, 31–33] confirmed that the podocyte is the primary culprit
in the development of FSG.
Primary collapsing glomerulopathy is a particular form of FSG
that has recently elicited considerable interest. Collapsing FSG is
not a new entity but its incidence has increased over the last
twenty years [34–36], leading some nephrologists to evoke a
possible infectious/viral etiology [34].
The podocyte lesion that characterizes FSG, including collaps-
ing glomerulopathy [28, 30, 34], consists of swelling, vacuolization,
protein storage and lysosomal multiplication. Such modified
podocytes line up around the tuft and assume a “cobblestone”
appearance. Visceral epithelial cells detach from the underlying
GBM, and the resulting space, filled with new matrix material,
appears as a clear halo by light microscopy. In collapsing FSG
numerous podocytes clump in Bowman’s space, forming a pseu-
do-crescent. In the most severely damaged glomeruli the whole
tuft collapses. In other, less retracted glomeruli adhesions or
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“synechia” form between peripheral loops of the tuft and Bow-
man’s capsule. The podocytes and the opposing epithelial cells of
Bowman’s capsule are pushed aside by synechia, leading to the
typical lesion of FSG. These glomerular lesions are accompanied
by tubulointerstitial wasting, comprising tubular cell atrophy,
tubular dilatation and the presence of large proteinaceous tubular
casts. The cause of such devastating podocyte aggression and of
the accompanying tubulointerstitial damage is still unknown.
We thus undertook a study of primary collapsing glomerulopa-
thy, focusing on podocytes. We show, for the first time in human
disease, that when no longer tethered to the GBM, or when
assuming the dysmorphic appearance of “cobblestones,” podo-
cytes are shed into the urinary space, lose their specific markers
and acquire macrophagic-related epitopes. These findings are
substantiated by experiments using rat models of glomerular cell
culture, which have demonstrated that podocytes can change into
antigen-presenting cells [37] or into macrophagic cells [38]. In
addition, we show that cells with macrophagic-like phenotypes are
also found in the tubular lumens.
METHODS
Patients
We studied the renal tissue of eight patients, four males and
four females, who were referred to our Nephrology Unit for
nephrotic range proteinuria with renal failure in seven and a rapid
course to ESRD in three (Table 1). The main data regarding these
patients are summarized in Table 1. Five of them were Black.
Their mean age at the time of renal biopsy was (mean 6 SD) 42 6
11.7 years (range 28 to 57 years). All were human immunodefi-
ciency virus (HIV) negative on two tests. None of them was a user
of illicit drugs. Renal tissue samples were obtained percutaneously
in six patients. In one, samples were obtained surgically, and in
another, whose collapsing glomerulopathy had relapsed after
renal transplantation and who returned to maintenance hemodi-
alysis, transplantectomy provided the whole kidney for histologic
examination. None of the samples contained less than eight
non-obsolescent glomeruli. A typical picture of collapsing glo-
merulopathy was found in all patients.
Standard microscopy
The renal samples were processed for light microscopy and
immunofluorescence using standard techniques. Immunofluroes-
cence was performed using antisera directed against IgG, IgA,
IgM, C3, C1q, fibrinogen, albumin (Behringwerke, Marburg,
Germany) and k and l light chains (Dakopatts A/S, Glostrup,
Denmark).
Immunohistochemistry
Podocytes were identified by presence of the glycocalyx sialo-
glycoprotein podocalyxin, of vimentin, a protein of the podocyte
cytoskeleton [39, 40], and of complement receptor 1 (CR1) [41].
These three phenotypes were characterized using two anti-podo-
calyxin monoclonal antibodies (mAbs) raised against human
podocalyxin identified by Western blot, a kind gift of Dr. Pierre
Ronco (INSERM U 489, Hoˆpital Tenon, Paris, France), an
anti-human mAb (Dakopatts) and a mouse anti-human C3b
receptor (CR1, clone J3D3) [42], a kind gift of Dr. Michel
Kazatchkine (INSERM U 430, Hoˆpital Broussais, Paris, France).
To further characterize the phenotypic expression of swollen,
vacuolated, cobblestone-like and/or detached podocytes, we used
three anti-human mAbs with different specificities for macroph-
age-associated epitopes: an anti-CD68 clone KP1 (Dakopatts), an
anti-CD68 clone PG-M1 (Dakopatts) and an anti-human macro-
phage clone M 18 (Ber-MAC3; Dakopatts). For KP1 and PG-M1,
4-mm thick paraffin sections of renal tissue were fixed in Bouin
solution or in formalin. Slides were deparaffinized and rehy-
drated. Immunohistochemical staining was performed by two
methods: the ABC method using avidin-biotin system with alka-
line phosphatase enzyme (Vector Laboratories, Burlingame, CA,
USA) and the streptavidin-biotin peroxidase system (Biogenex).
Ber-MAC3 identification was carried out on cryostat sections,
using the ABC method described below.
Immunostaining was performed by the ABC alkaline phospha-
tase procedure (Vector Laboratories) involving: (1) blocking with
normal horse serum diluted 1/20 for 20 minutes; (2) 30 minute
incubation with primary mouse anti-human mAbs (anti-vimentin,
anti-CR 1 or anti-human macrophage markers KP-1, PGM-1 and
Table 1. Main clinical data in 8 patients with collapsing glomerulopathy
Patient
no. Age Sex
Ethnic
origin
(birthplace) Mode of onset
Blood
pressure
mm Hg
Serum
creatinine
mmol/liter
24-hour
proteinuria
g
Serum
albumin
g/dl Kidney size Outcome
1 56 F B (Antilles) Oligoanuria 220/130 1280 50 g/liter
(sample)
1.45 large HD (died after 3
mo)
2 28 F W (Algeria) Progressive NS 180/110 247 3 2.8 small 6 months; HD
3 45 M W (France) Progressive NS
over 2 years
160/110 210 3.45 3.5 normal 3 years; HD
4 31 F B (Antilles) Acute NS 100/70 149 32 1.3 normal 1 year; NS
5 29 M B (Africa) Acute NS 160/110 122 7 2.05 normal 1 year; PR
6 36 M B (Antilles) NS, ARF 150/110 1230 17 1.01 large 1 year; HD, T
7 57 M B (Africa) Fever, NS, ARF 120/90 1600 7.4 2.0 large 8 years; CR with
steroids 1
azathioprine
8 54 F W (France) Progressive NS, 3
years after T
210/106 349 3 3.2 transplanted
kidney
6 months; HD
Abbreviations are: W, White; B, Black; NS, nephrotic syndrome; ARF, acute renal failure; HD, hemodialysis; T, transplantation; CR, complete
remission of NS; PR, partial remission of NS.
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M 18); (3) after washing in PBS buffer, pH 7.4, 30 minute
incubation with biotinylated secondary antibody, a horse anti-
mouse mAb; and (4) after washing, 30 minute incubation with a
preformed avidin-biotinylated alkaline phosphatase complex. The
indicator system was developed with Vector Red substrate (Vec-
tastain, ABC Kits; Vector Laboratories). Slides were counter-
stained with hematoxylin.
Double labeling was performed using the ABC alkaline phos-
phatase procedure, comprising six steps for the first labeling: (1)
digestion by pronase for 10 minutes at room temperature; (2)
blocking for 20 minutes with normal horse serum diluted 1/10; (3)
30 minutes incubation with a mouse anti-human podocalyxin
mAb; (4) after washing in PBS buffer, pH 7.4, 30 minute
incubation with the biotinylated horse anti-mouse Mab; (5) after
washing, 30 minute incubation with a preformed avidin-biotiny-
lated alkaline prosphatase complex; (6) after washing, develop-
ment of the indicator system on the Vector Blue substrate. The
procedure was the same for the second labeling, except that in
Step 3 the anti-CR 1 mAb (clone J3D3) or the anti-CD68 (clone
PG-M1) was used, and in Step 6 the indicator system was
developed with Vector Red substrate.
The following negative control experiments were carried out on
paraffin and cryostat sections: (1) replacement of the primary
mAb with antibody-diluting buffer; (2) replacement of the pri-
mary mAb by mouse anti-cytomegalovirus mAb, clone EB
(Clonatec Biosoft, Paris, France); (3) replacement of the primary
mAb by normal mouse serum.
RESULTS
Light microscopy and immunofluorescence
By light microscopy, collapsing glomerulopathy was observed
on all specimens (Fig. 1). Most, but not all glomeruli showed
segmental or global collapse of the glomerular capillary walls,
podocyte vacuolization and multinucleation of some podocytes. In
a majority of glomeruli cobblestone-like podocytes were aligned
around the collapsed glomerular tuft and still adhering to the
underlying glomerular basement membrane (GBM). Typical le-
sions of FSG, characterized by increased extracellular matrix
proteins, hyalinosis and capsular adhesions, were observed in
numerous, incompletely collapsed glomeruli. In some glomeruli,
the mono- or multinucleated visceral epithelial cells formed
pseudo-crescents, and many contained hyaline protein resorption
droplets. The pseudo-crescents differed from true crescents, as
they were adjacent to the tuft and not to Bowman’s capsule, they
were composed of round cells, and they were not surrounded by
extracellular matrix material. The visceral epithelial cells forming
these pseudo-crescents had the appearance of living cells. Some
podocytes were detached from the underlying GBM and were
drifting in Bowman’s space. Bowman’s capsules were intact, with
no gaps or perforations and no evidence of cell trafficking from or
to the interstitium. Numerous microcystic dilated tubules were
filled with proteinaceous casts. Marked dilation affected other
tubules throughout the cortex and the medulla. By immunofluo-
rescence, the hyaline droplets within hypertrophied podocytes
were strongly labeled with albumin and IgA, indicating protein
phagocytosis.
Immunohistochemistry
Identification of podocytic markers. Three podocytic markers
were studied: vimentin, podocalyxin, and CR1. Basically, the three
markers diclosed similar labeling pattern changes according to
podocyte attachment to, or detachment from the underlying
GBM.
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Fig. 1. Patient number 1, showing collapsing glomerulopathy. The lesions of the glomerulus are typical. The glomerular tuft is severely retracted. The
podocytes are hyperplastic. Some podocytes are detached from the remaining visible portion of the tuft. They appear swollen and some of them are
multinucleated. The arrow indicates a podocyte with three nuclei. Other podocytes are completely detached and appear free in Bowman’s space
(arrowhead). Note the integrity of Bowman’s capsule. A tubule (double arrow) with a flattened epithelium and a widened lumen is occupied by a number
of round-shaped cells with intact nuclei which appear morphologically almost identical to the podocytes clumped in the urinary glomerular chamber
(Masson’s trichrome; 3250).
Fig. 2. Patient number 2 showing anti-human vimentin. The normal podocytes are stained bright red. This figure illustrates the appearance of a
non-collapsed glomerulus in a case of collapsing glomerulopathy. The most altered segment of the tuft is consolidated and its outer aspect is lined by
a row of cobblestone-like cells (arrowhead). These cells are vimentin negative. The rest of the tuft still contains open capillaries. Preserved podocytes
are stained red (arrow) (3400).
Fig. 3. Patient number 6, showing anti-human podocalyxin. The normal podocytes are stained bright red. The upper left half of the glomerulus is
severely altered. A row of cobblestone-like podocytes is indicated by the arrowhead. There is virtually no labeling with podocalyxin in this area. The right
half of the glomerulus (arrow) is relatively preserved, with open capillaries. The capillary endothelium is stained bright red by the anti-podocalyxin
antibody (3400).
Fig. 4. Patient number 1 showing anti-human podocalyxin. Close-up of part of the glomerular tuft, at the urinary pole of the tuft (compare with Figs.
5 and 6). The glomerular tuft is completely collapsed. The anti-podocalyxin antiserum labels capillary endothelial cells. Podocytes are podocalyxin
negative (3400).
Fig. 5. Same glomerulus, serial section to Figure 4. Monoclonal mouse antibody against human CR1. All podocytes are CR1 negative, including those
still aligned along the outer aspect of the tuft and those detached and shed into the urinary chamber (3400).
Fig. 6. Same glomerulus, serial section to Figure 5. Monoclonal mouse anti-human macrophage, CD68, clone KP1. All cells of the glomerular tuft
including cobblestone-like podocytes are negative. Detached podocytes in the urinary chamber are stained bright red (3400).
Fig. 7. Patient number 8, showing antibody against human CD68, clone PG M1. Three atrophic tubules with microcystic changes. The lumen of the
upper tubule is almost occluded by a clump of macrophage-like cells. Their nuclei are apparently normal, giving the impression that these cells are viable.
The two other tubules are considerably dilated, with a microcystic appearance. Their epithelium is flattened and the lumen is entirely filled with large
proteinaceous casts. No CD68 labeled cells are present in the infiltrate that occupies the peritubular interstitium (3300).
Fig. 8. Patient number 7, showing antibody against human CD68, clone PG M1. The lumen of a small caliber tubule, presumably distal, shows a line
of macrophagic cells. They seem to progress in single-file, following the urinary flow. A nearby small inflammatory infiltrate is devoid of any
macrophage-like cellular elements (3400).
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Vimentin labeling. Anti-vimentin antibody variably labeled
podocytes according to the severity of lesions.
When glomerular tufts or lobules were little affected, the
labeling pattern was normal. When still attached to the tuft,
vacuolated podocytes had a vimentin-positive cytoplasm. Cobble-
stone-like and completely detached podocytes were vimentin
negative (Fig. 2). Examination of nephron segments further
downstream, from Bowman’s space to tubular lumens, showed
that cells in the urinary space were vimentin negative.
Podocalyxin labeling. In relatively preserved glomeruli, podoca-
lyxin labeling was normally distributed. Podocyte immunostaining
circled the tuft lobules and tagged the capillary endothelium. In
glomeruli containing vacuolated podocytes still attached to the
GBMs, podocalyxin surrounded and circled the bullous vacuoles.
In more altered glomeruli, with a consolidated tuft surrounded
with cobblestone-like podocytes, podocalyxin labeling was nega-
tive, except in a few remaining lobules with no cobblestone-like
alignment and having open capillaries. In consolidated glomeruli
where podocytes were completely detached, podocalyxin labeling
marked only the capillary endothelium (Figs. 3 and 4).
CR1 labeling. CR1 labeling also differed according to podocyte
attachment to, or detachment from, the glomerular tuft. Normal,
podocytes were invariably labeled by CR1. Swollen podocytes still
anchored to the GBM and having a “bullous” appearance were
CR1 positive. Cobblestone-like podocytes lining the glomerular
tuft and detached podocytes had lost this labeling (Fig. 5).
Identification of macrophage-associated markers
We particularly focused on the podocytes remaining attached
to, or in the process of detachment from the GBM, and on the
detached cells free in Bowman’s space or in the tubular lumen
(Fig. 6, 7 and 8).
Regarding glomerular cells, similar results were observed using
three different mAbs recognizing macrophage-associated
epitopes: anti-CD68 clone KP1, anti-CD68 clone PG-M1 and
anti-human M 130, M 18 (Ber-MAC3). Tissue preservation was
better in paraffin than in cryostat sections. This applied to KP1
and PG-M1, as the M 18 (Ber-MAC3) epitope was no longer
expressed after fixation and thus could only be studied on cryostat
sections. Cytoplasmic labeling appeared smooth and homoge-
neous with anti-CD68 clone PG-M1 whereas it had a granular
character with anti-CD68 clone KP1.
There was no correlation between the severity of podocyte
vacuolization, cobblestone-like alignment along the outer aspect
of the glomerular lobule and detachment into Bowman’s space on
the one hand, and the number of detached podocytes with a CD68
labeling. Podocytes still present within the glomerular tuft or
those covering the outer aspect of the GBM were KP1, PG-M1
and M 18 negative (Fig. 6). Once detached from the GBM and
free within Bowman’s space they expressed the three macroph-
age-associated markers. The most striking localization was a
clustering of labeled podocytes at the glomerular tip, clumping
within the outlet to the proximal tubule (Fig. 6). On rare sections
one or two small CD681 cells were seen close to Bowman’s
capsule. It was not morphologically possible to distinguish
whether they were podocytes or parietal epithelial cells. In the
majority of sections observed cells labeling as macrophages were
absent from the glomerular capillary lumens. Few labeled cells
were visible in the periglomerular interstitium, but their number
and distribution were those of normal interstitial macrophages.
Another constant feature was the presence of CD68 and M 18
(Ber-MAC3) labeled cells within the tubules. In some profoundly
altered, dilated and atrophic tubules, they were clumped in
clusters comprising more than 30 cells on some single sections
(Fig. 7). In other sections showing tubules of small caliber,
presumably distal, the macrophage-like cells were aligned in
single file (Fig. 8). None had pyknotic nuclei. Several were
multinucleated and their appearance was that of viable cells.
Sparse macrophagic cells were occasionally found within the
interstitium, including inflammatory infiltrates surrounding the
glomerular and tubular areas containing macrophage-like cells.
However, these macrophagic cells were relatively distant from the
glomeruli and from the tubules, with no contact with Bowman’s
capsule or tubular basement membranes. Overall, from glomeru-
lus to tubule, macrophage-like cells were essentially confined to
the urinary space, and there was no morphological indication that
they originated from outside the glomerulus or from outside the
tubule.
Double labeling (not shown)
Podocalyxin 1 CR1 labeling. Fairly well preserved glomeruli
were labeled with both podocalyxin and CR1. More altered
glomeruli had a few preserved lobules in which streaks of podo-
calyxin were still visible whereas CR1 labeling was negative. In
collapsed and consolidated glomeruli surrounded by cobblestone-
like podocytes, both podocalyxin and CR1 labeling was negative.
Podocalyxin 1 PGM1 labeling. No simultaneous labeling was
seen with both podocalyxin and PGM1. All PGM1 positive cells
were podocalyxin-negative.
DISCUSSION
Focal segmental glomerulosclerosis (FSG) is a lesion common
to a number of renal diseases [7]. The primary renal injury can be
glomerular, interstitial or vascular [4, 6, 7]. Conditions as different
as morbid obesity [43], reflux nephropathy [6], HIV infection [44],
and cholesterol embolism [8] rank among the various circum-
stances in which renal biopsy can disclose FSG, confirming that
FSG is a “nonspecific glomerular appearance seen on histological
examination of the kidney, and not a disease entity” [1]. However,
the common denominator in all forms of FSG is the primary
podocyte involvement, which is not identical in the rat and in
human.
Kriz and coauthors have studied FSG in rat models based on
subtotal renal tissue ablation [18, 21, 32, 33, 45] where the
increased surface area of peripheral capillary walls results from
inordinate glomerular volume enlargement [32, 33, 45]. This
volume must be covered by podocytes, which in this model do not
undergo hyperplasia, but only hypertrophy [4, 6, 7, 21]. However,
podocyte changes are also observed in other rat models in which,
initially, there is no renal mass reduction and no glomerular
hyperfiltration/hypertension [10–12, 20, 46], as confirmed by
micropuncture analysis [9]. Also, Floege and coauthors demon-
strated that in the rat with passive Heymann nephritis, a model in
which the podocyte is the primary target of antibody and C5b-9
mediated injury, visceral glomerular epithelial cells can undergo
mitosis and proliferate in vivo [20].
Podocyte hyperplasia (as opposed to hypertrophy) has been
consistently observed in the cellular variant of human FSG,
including collapsing glomerulopathy [7, 27, 30, 34–36] and relapse
of nephrotic syndrome in transplanted kidneys [30, 47]. These
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forms are characterized by tuft retraction and collapse in which
the podocyte appears to be the culprit of glomerular tuft wasting
rather than the victim of capillary distension. The pending ques-
tions are: what is the pathophysiology of podocyte changes and
hyperplasia, and do these detached cells undergo phenotypic
transformation? Our study brings new elements to help answer
the second question.
We confirm the aforementioned publications describing re-
markable changes in podocyte morphology and location in col-
lapsing glomerulopathy, and we show that, along with dislodging,
podocytes undergo phenotypic transformation. Those still at-
tached to the GBM still express podocalyxin, CR1 and vimentin
epitopes. Once assuming the cobblestone-like alignment, or de-
tached from the tuft and moving free in the urinary space, they
lose normal podocyte phenotypes and acquire macrophage-asso-
ciated phenotypes, a sequence of events that closely resembles
what has been described in rat podocyte cultures [38].
Our immunohistochemical study was essentially based on iden-
tification of podocyte-associated antigens and of macrophage-
associated antigens. Was this identification adequate?
Among resident glomerular cells, podocytes can be character-
ized by specific proteins [40] that play a major role in maintaining
the glomerular architecture and filtration barrier. Podocalyxin is
the main glomerular sialoglycoprotein, localized over the apical
domain of the podocyte but absent from the soles of the foot
processes. It bears most of the anionic charges of the glycocalyx
and plays a major role in maintaining podocyte architecture [40,
48]. Vimentin is one of the cytoskeletal constituents of interme-
diate filaments observed in the cell body but not in the foot
processes [38, 39, 49]. Mesangial cells, parietal epithelial cells and
macrophages do not contain vimentin, which is an adequate
marker of podocytes when normally anchored to the GBM by
a3b1 integrin. In humans, but not in other species, CR1 is
distributed along the whole plasmic membrane. Its role is un-
known. Podocytes lose these specific marker proteins in early cell
cultures [38, 50], and it could be expected that similarly, in human
disease, podocytes free of GBM attachment and drifting into the
urinary space are no longer tagged with their normal epitopes. In
our study, this loss of specific podocyte phenotypes was shown by
studying these detached cells. Attached normal or vacuolated
podocytes were vimentin positive. Those free in the urinary space
as well as those assuming a cobblestone-like appearance had lost
vimentin marking. Loss of podocalyxin followed the same pattern.
Podocytes were CR1 positive when they were normally located
within the tuft, but CR1 labeling was negative when they assumed
a cobblestone appearance. CR1 was the first, or at least the most
completely lost of the antigens studied.
Regarding macrophagic associated epitopes of the CD68 clus-
ter, three mAbs were used. KP-1 reacts with human monocytes,
macrophages and myeloid cells [51–53]. This CD68 epitope resists
fixation and embedment. In monocytes it is detected within
cytoplasmic granules, colocalized with lysozyme and myeloperox-
idase [54]. PGM-1 reacts with monocytes and macrophages, but
not myeloid cells [55], and reacts strongly with a fixative-resistant
epitope of an intracytoplasmic molecule selectively expressed by
virtually all macrophages. M 18 (Ber-MAC3) [56] reacts only with
tissue macrophages and activated monocytes. It recognizes a
formol-sensitive epitope expressed on the cell surface and in the
cytoplasm [57, 58]. This antigen has been designated M130 and is
of interest because its distribution is restricted to cells of the
mononuclear phagocyte lineage. It belongs to the scavenger
receptor superfamily [59].
Identification of KP1 and PG-M1 on detached podocytes is not
sufficient evidence that these cells are stricto sensu macrophages.
Acquisition of macrophagic associated antigens of the CD68
family has been described in various cell lines. Such immunore-
activity for KP1 was identified in malignant neoplasms, including
lymphomas, sarcomas and carcinomas [60–62], in neoplastic
human mast cells [63], in benign neural tumors [64] and in
Schwann cells in neoplastic neural tissue [65]. PGM-1 have been
found in neoplastic human tissue mast cells [66] and angiomyoli-
poma of the kidney [67]. Taken together, these findings indicate
that immunoreactivity with KP1 and PG-M1 can be expected in
cells that do not belong to the classical mononuclear phagocyte
system if they exhibit phagocytosis and/or autophagy. M 18
(Ber-MAC3) [56] is highly specific of tissue macrophages and its
reactivity with blood monocytes is negative on freshly isolated
cells and weakly positive on cultured cells.
These are consistent reasons to believe that macrophage-like
cells found in the urinary space were metaplastic podocytes and
were not the result of bone marrow-derived macrophage traffick-
ing through Bowman’s capsule, from within the glomerular tuft or
from outside the tubular basement membrane.
Our findings are corroborated by recent experiments based on
normal rat glomerular cell culture. Mendrick, Kelly and Rennke
[37] demonstrated that glomerular epithelial cells acquire in vitro
the ability to process and present antigens. Orikasa [38] estab-
lished methods for culturing rat glomerular cells that were
confirmed to be derived from podocytes. The source of these cells
was whole glomeruli isolated by graded sieving technique. A
kinetic study on days 3 to 11 of culture showed that cells identified
as podocytes changed into macrophagic cells that migrated from
the glomeruli. While cultured, podocytes lost both the electron
microscopic appearance and some immunohistochemical markers
of glomerular visceral epithelial cells and acquired morphological
and functional characteristics of macrophages. This elegant ex-
periment, which clearly showed the temporal and spatial devel-
opment from GBM-attached podocytes to free macrophage-like
cells, strongly supports our findings in collapsing glomerulopathy.
In summary, we show by standard microscopy and by immuno-
histochemistry that, in collapsing glomerulopathy, glomerular
visceral epithelial cells undergo profound morphological changes,
including multinucleation and detachment from the GBM. Dur-
ing this process, which follows an aggression of undetermined
nature, podocytes lose normal podocytic phenotypes and change
into cells expressing macrophage associated epitopes. Cells ex-
pressing the same macrophage associated epitopes are also
present in the tubular lumens. The significance and consequences
of these findings regarding the natural history of collapsing
glomerulopathy await elucidation.
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